Cases

Takeda Pharmaceutical Company Limited - Sale of healthcare business to Blackstone

Leading Japanese law firm Nishimura & Asahi advised Takeda Pharmaceutical Company Limited (“Takeda”) [TSE: 4502/NYSE: TAK] on the sale of its subsidiary, Takeda Consumer Healthcare Company Limited, to The Blackstone Group Inc. [NYSE: BX] and its affiliates, for JPY 242 billion (approximately USD 2.3 billion). 

The Nishimura & Asahi team advising Takeda was led by partners Yo Ota, Hiroko Shibata and Taeko Morita, supported by Hiroyuki Kikuchi and Yutaka Ito.